BiOptix, Inc.
(NASDAQ : APPY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading APPY News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.09%68.891.0%$927.36m
AMGNAmgen Inc.
-0.40%171.920.8%$652.85m
BIIBBiogen Inc.
-1.44%283.500.9%$519.37m
CELGCelgene Corporation
-1.28%117.741.0%$474.82m
REGNRegeneron Pharmaceuticals, Inc.
-3.26%358.171.9%$330.15m
ALXNAlexion Pharmaceuticals, Inc.
-1.24%129.212.0%$296.14m
TSROTESARO, Inc.
-3.61%183.0915.3%$188.85m
INCYIncyte Corporation
-2.07%118.852.3%$160.16m
ILMNIllumina, Inc.
-0.97%160.733.9%$143.06m
VRTXVertex Pharmaceuticals Incorporated
-1.56%84.452.6%$137.21m
EXELExelixis, Inc.
-3.43%21.855.5%$123.57m
CLVSClovis Oncology, Inc.
-4.63%58.3616.4%$121.74m
AAgilent Technologies, Inc.
0.00%51.341.7%$116.33m
ACADACADIA Pharmaceuticals Inc.
0.00%39.1419.0%$93.49m
BMRNBioMarin Pharmaceutical Inc.
-0.89%88.994.0%$89.62m

Company Profile

BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult patients. The company was founded on July 24, 2000 and is headquartered in Boulder, CO.